News

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.
WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
The FDA announced today that they've approved a twice-yearly injection for preventing HIV infection in adults and kids. News ...